European ophthalmologists debate

Article

European Ophthalmology, the social networking group for European ophthalmologists created and moderated by Ophthalmology Times Europe, has recently launched its new discussion forum.

European Ophthalmology, the social networking group for European ophthalmologists created and moderated by Ophthalmology Times Europe, has recently launched its new discussion forum.

We at Ophthalmology Times Europe want to know what you think on a variety of issues that impact directly on your community. A selection of the discussion comments posted will be published in a new feature in the magazine, starting next month. As the voice of the European ophthalmology community, we’d like to represent your views accurately, so your comments will be completely free from censorship: please feel free to discuss your opinions at will.

European Ophthalmology and Ophthalmology Times Europe have no material interest in these discussions: we merely wish to stimulate debate within the industry, and find out how you feel about issues affecting your industry, so that we can accurately represent and respond to your needs.

To become a member of our online community, please go to www.oteurope.com/forum. If you are already a member, please go to www.oteurope.com/discuss to start your own or join in with any of our current discussions.

In conjunction with the debates that we are running, we are also conducting a series of brief surveys (right), so even if your time is limited, you can still make your opinion count, simply at the touch of a button.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jeremiah Tao, MD, FACS, discusses his Egyptian Ophthalmological Society keynote, which focused on risk management and avoiding surgical complications in oculofacial surgery
Omer Trivizki, MD, MBA, a retina specialist from Tel Aviv Medical Center, speaks about VOY-101, a Novel, Complement-Modulating Gene Therapy for Geographic Atrophy at the American Society of Retina Specialists (ASRS) Annual Meeting
João Pedro Marques, MD, MSc, PhD discusses a retrospective study of 800 patients with inherited retinal diseases during the American Society of Retina Specialists (ASRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.